Pelthos Therapeutics Inc.
(NYSE Mkt: PTHS)
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform "Nitricil". Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
25.265
-1.095
(-4.15%)
Range
24.670 - 27.074
(9.74%)
Open
26.400
Previous Close
26.360
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
10,486
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:56.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
